Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.27
0.00 (0.10%)
At close: Apr 28, 2026, 4:00 PM EDT
5.26
0.00 (-0.09%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Journey Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Journey Medical stock have an average target of 12.67, with a low estimate of 12 and a high estimate of 13. The average target predicts an increase of 140.65% from the current stock price of 5.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2026.
Analyst Ratings
The average analyst rating for Journey Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +146.91% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +146.91% | Aug 25, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $9 → $13 | Strong Buy | Maintains | $9 → $13 | +146.91% | Aug 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +127.92% | Jul 30, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +70.94% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
86.43M
from 61.86M
Increased by 39.72%
Revenue Next Year
141.09M
from 86.43M
Increased by 63.24%
EPS This Year
0.07
from -0.47
EPS Next Year
1.04
from 0.07
Increased by 1,303.45%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 96.1M | 167.2M | |
| Avg | 86.4M | 141.1M | |
| Low | 78.5M | 119.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 55.3% | 93.4% | |
| Avg | 39.7% | 63.2% | |
| Low | 26.9% | 38.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.23 | 1.69 | |
| Avg | 0.07 | 1.04 | |
| Low | -0.10 | 0.44 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 2,186.0% | |
| Avg | - | 1,303.4% | |
| Low | - | 496.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.